DVA - DaVita HealthCare Partners Projected Price to Earnings

DaVita Corp - graphic logo of issuer DVA

DaVita Inc. revenues are based on a network of hemodialysis centers and laboratory tests. Strategic priority is given to partnerships with insurance groups and hospitals to implement value-based care, which increases therapy accessibility. The company's projected P/E valuation confirms this trend, with the indicator reaching 10.40. Simultaneously, the business is implementing predictive software and elements of medical robotics.

DVA - davita.com Price to Future Earnings Ratio over the range 07/04/2022 - 11/16/2026

Analytical breakdowns for DaVita Inc. (DVA)

- stock value and consensus price forecast:
Basic company analysis:DaVita DVA
Product sample of DaVita Corp

Stable revenue streams for DaVita Inc. (DVA) are secured by a global network of dialysis centers and long-term insurance agreements. By analyzing the company's current forward P/E, an investor sees the ratio of market value to expected net income. This metric measures the cost of one dollar of future earnings, filtering out short-term price volatility. Low values indicate that the asset is undervalued relative to its potential. This allows for an assessment of the business's fundamental stability within the long-term consensus.

Key competitors

Future Price to Earnings HCA Holdings (HCA)|Tenet Healthcare - Price to Future Earnings Ratio|Fresenius Medical Care Corp - Projected Price to Earnings|SOLV: Price to Future Earnings Ratio|Encompass - Forward P/E Multiple|UHS - Forward P/E Multiple|RadNet Corp (RDNT) - Future Price to Earnings|Projected Price to Earnings Ratio Option Care Corp (OPCH)|Projected Price to Earnings SGRY|PINC: Future Price to Earnings Multiple|Forward P/E Multiple EYE|PGNY - Projected Price to Earnings Ratio|Forward P/E Multiple ARDT (ardenthealth.com)|SEM - Projected Price to Earnings|Astrana Corp - Forward P/E Multiple|Future Price to Earnings Multiple MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Future Price to Earnings|Projected Price to Earnings Ratio Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - Forward P/E Multiple|NUTX: Future Price to Earnings Multiple|Forward P/E Multiple AUNA|Projected Price to Earnings SBC Medical Group Holdings Inc SBC|Future Price to Earnings Jeuveau EOLS|Future Price to Earnings Multiple CYH|SKIN: Projected Price to Earnings|Future Price to Earnings Multiple MDWD (MediWound)|BTMD (biote.com) - Projected Price to Earnings|Projected Price to Earnings thejoint.com|DCGO (DocGo, Inc.) - Forward P/E Multiple|Future Price to Earnings PIII|Projected Price to Earnings GANX (Gain Therapeutics Inc.)|Forward P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Projected Price to Earnings|Market Cap to Future Earnings Ratio CLGN (CollPlant Ltd)|cuprina.com.sg - Forward P/E Multiple|Future Price to Earnings Multiple CCM (Concord Medical Services Holdings)|AMS: Forward P/E Multiple|Projected Price to Earnings Ratio MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - Forward P/E Multiple|Price to Future Earnings Ratio DHAI (DIH Holding US, Inc.)|Forward P/E Multiple XAGE|Market Cap to Projected Earnings NewGenIvf Group|Future Price to Earnings ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Projected Price to Earnings Ratio|KDLY - Future Price to Earnings|Future Price to Earnings Multiple MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Future Price to Earnings|SSY - Market Cap to Projected Earnings|Future Price to Earnings IMAC Holdings Inc